Covered recipient · General Payments record
MOHAMMAD ATHARI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$14,715.42
- Reported across 1,034 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $551.07 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $208.87 | 20 |
| Neurelis, Inc. | $77.14 | 2 |
| ACADIA Pharmaceuticals Inc | $54.02 | 3 |
| Axsome Therapeutics, Inc. | $47.11 | 2 |
| SK Life Science, Inc. | $41.68 | 2 |
| PFIZER INC. | $30.53 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $22.93 | 1 |
| Amgen Inc. | $22.47 | 1 |
| Amneal Pharmaceuticals LLC | $16.03 | 1 |
| Lilly USA, LLC | $15.51 | 1 |
| SCILEX PHARMACEUTICALS INC. | $14.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.31 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249379 | CMS |
| ABBVIE INC. | $4.52 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249381 | CMS |
| ABBVIE INC. | $23.37 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249383 | CMS |
| ABBVIE INC. | $5.04 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249385 | CMS |
| ABBVIE INC. | $14.71 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249387 | CMS |
| ABBVIE INC. | $5.65 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249389 | CMS |
| ABBVIE INC. | $5.04 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249391 | CMS |
| ABBVIE INC. | $17.12 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249393 | CMS |
| ABBVIE INC. | $15.56 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249395 | CMS |
| ABBVIE INC. | $6.55 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249397 | CMS |
| ABBVIE INC. | $6.15 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249399 | CMS |
| ABBVIE INC. | $5.65 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249401 | CMS |
| ABBVIE INC. | $12.02 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249403 | CMS |
| ABBVIE INC. | $5.79 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249405 | CMS |
| ABBVIE INC. | $8.12 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249407 | CMS |
| ABBVIE INC. | $11.21 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249409 | CMS |
| ABBVIE INC. | $6.22 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249411 | CMS |
| ABBVIE INC. | $21.30 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249413 | CMS |
| ABBVIE INC. | $13.54 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249415 | CMS |
| ABBVIE INC. | $6.00 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103249417 | CMS |
| ACADIA Pharmaceuticals Inc | $21.17 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147962345 | CMS |
| ACADIA Pharmaceuticals Inc | $17.20 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147962347 | CMS |
| ACADIA Pharmaceuticals Inc | $15.65 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147962349 | CMS |
| Amgen Inc. | $22.47 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115431123 | CMS |
| Amneal Pharmaceuticals LLC | $16.03 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139179431 | CMS |
| Axsome Therapeutics, Inc. | $24.53 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148306778 | CMS |
| Axsome Therapeutics, Inc. | $22.58 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148306780 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $22.93 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144451223 | CMS |
| Lilly USA, LLC | $15.51 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135244439 | CMS |
| Neurelis, Inc. | $36.09 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145632235 | CMS |
| Neurelis, Inc. | $41.05 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145632239 | CMS |
| PFIZER INC. | $15.37 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131238464 | CMS |
| PFIZER INC. | $15.16 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131485298 | CMS |
| SCILEX PHARMACEUTICALS INC. | $14.78 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136216191 | CMS |
| SK Life Science, Inc. | $23.68 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154124487 | CMS |
| SK Life Science, Inc. | $18.00 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154124495 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.